InVivo Therapeutics
-
Neuro
InVivo Therapeutics to Present and Exhibit at Spine Summit 2017
February 28, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that two INSPIRE study Principal Investigators, Dom Coric, M.D.…
Read More » -
Hospitals
InVivo Therapeutics Announces Approval for INSPIRE Pivotal Probable Benefit Clinical Study of the Neuro-Spinal Scaffold™
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) announced that it has received approval of a protocol amendment from the U.S. Food…
Read More » -
Hospitals
InVivo Therapeutics receives conditional FDA approval for INSPIRE pivotal probable benefit study
InVivo Therapeutics announced the FDA has given the company conditional approval to convert an ongoing study into the pivotal probable…
Read More » -
Biologics
InVivo Therapeutics Announces Jay Blackington as New Vice President, Head of Human Resources
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Jay Blackington as Vice President, Head of Human Resources.…
Read More » -
Spine
InVivo Therapeutics Reports Significant Improvement of First Patient Implanted with Neuro-Spinal Scaffold™
CAMBRIDGE, Mass., Oct 23, 2015 (BUSINESS WIRE) — InVivo Therapeutics Holdings Corp. (NVIV) today announced a 12-month post-implant update for the first…
Read More » -
Spine
InVivo’s pilot study expands to 10 spinal cord injury patients — 5 key notes
By Laura Dyrda The FDA approved an expansion for the InVivo pilot study for the investigational Neuro-Spinal Scaffold. Here are five key…
Read More » -
Hospitals
InVivo Therapeutics Announces Expansion of Number of Patients in Pilot Study InVivo Therapeutics Holdings Corp.
InVivo Therapeutics Holdings Corp. (NVIV) today announced that the U.S. Food and Drug Administration (FDA) has approved the expansion of the…
Read More » -
Spine
Neuro-Spinal Scaffold for Repair of Spinal Cord Injuries: Interview with InVivo CEO
By Rachel Kessler InVivo Therapeutics, a company in Cambridge, MA, is developing a new way to treat patients with acute…
Read More » -
Spine
InVivo Therapeutics to Present at the Stem Cell Meeting on the Mesa
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) announced today that Thomas Ulich, M.D., Chief Scientific Officer, will present at the annual…
Read More » -
Neuro
InVivo Therapeutics to Present and Exhibit at the 65th CNS Annual Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the company will be giving a poster presentation and exhibiting at…
Read More » -
Spine
InVivo Therapeutics Announces Enrollment of Fifth Patient in Pilot Spinal Cord Injury Study
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the fifth patient has been enrolled in the company’s ongoing pilot…
Read More » -
Spine
InVivo Therapeutics Featured in Front Page Article in The Boston Globe
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) has announced that the company and the company’s ongoing trial of its investigational Neuro-Spinal…
Read More » -
Spine
InVivo Therapeutics to Present at the 17th Annual Spinal Research Network Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Alex Aimetti, Ph.D., Senior Director, Medical Education and Scientific Support, will…
Read More » -
Spine
InVivo Therapeutics Announces Enrollment of Fourth Patient in Pilot Spinal Cord Injury Trial
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that a fourth patient has been enrolled in the company’s ongoing pilot…
Read More » -
Spine
10 things for spine surgeons to know for Thursday — August 13, 2015
By Megan Wood Here are 10 things for spinal surgeons to know for August 13, 2015. Dr. Steven Falowski performs…
Read More »